The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Vasculitis Treatment Market Research Report 2024

Global Vasculitis Treatment Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1908045

No of Pages : 103

Synopsis
Vasculitis is a general term that refers to inflammation of blood vessels. When blood vessels become inflamed, they may become weakened, stretch, and either increase in size or become narrow -- even to the point of closing entirely. Vasculitis can affect people of all ages, but there are types of vasculitis that occur in certain age groups more often than others.
The global Vasculitis Treatment market was valued at US$ 408.2 million in 2023 and is anticipated to reach US$ 531 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vasculitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vasculitis Treatment.
Report Scope
The Vasculitis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vasculitis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vasculitis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Ablynx
Amgen
Anthera Pharmaceuticals
Aspen Pharmacare Holdings
Astrazeneca
Baxter
Biogen
Bristol-Myers Squibb
Celgene
Celltrion
Chemocentryx
Chugai Pharma Usa
Eisai
Eli Lilly
F. Hoffmann-La Roche
Genentech
Gilead
Glaxosmithkline
Human Genome Sciences
Segment by Type
Large Vasculitis Treatment
Medium Vasculitis Treatment
Small Vasculitis Treatment
Segment by Application
Hospitals And Clinics
Diagnosis Center
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vasculitis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vasculitis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Large Vasculitis Treatment
1.2.3 Medium Vasculitis Treatment
1.2.4 Small Vasculitis Treatment
1.3 Market by Application
1.3.1 Global Vasculitis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals And Clinics
1.3.3 Diagnosis Center
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vasculitis Treatment Market Perspective (2019-2030)
2.2 Vasculitis Treatment Growth Trends by Region
2.2.1 Global Vasculitis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Vasculitis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Vasculitis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Vasculitis Treatment Market Dynamics
2.3.1 Vasculitis Treatment Industry Trends
2.3.2 Vasculitis Treatment Market Drivers
2.3.3 Vasculitis Treatment Market Challenges
2.3.4 Vasculitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vasculitis Treatment Players by Revenue
3.1.1 Global Top Vasculitis Treatment Players by Revenue (2019-2024)
3.1.2 Global Vasculitis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Vasculitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vasculitis Treatment Revenue
3.4 Global Vasculitis Treatment Market Concentration Ratio
3.4.1 Global Vasculitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vasculitis Treatment Revenue in 2023
3.5 Vasculitis Treatment Key Players Head office and Area Served
3.6 Key Players Vasculitis Treatment Product Solution and Service
3.7 Date of Enter into Vasculitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vasculitis Treatment Breakdown Data by Type
4.1 Global Vasculitis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Vasculitis Treatment Forecasted Market Size by Type (2025-2030)
5 Vasculitis Treatment Breakdown Data by Application
5.1 Global Vasculitis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Vasculitis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Vasculitis Treatment Market Size (2019-2030)
6.2 North America Vasculitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Vasculitis Treatment Market Size by Country (2019-2024)
6.4 North America Vasculitis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vasculitis Treatment Market Size (2019-2030)
7.2 Europe Vasculitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Vasculitis Treatment Market Size by Country (2019-2024)
7.4 Europe Vasculitis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vasculitis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Vasculitis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Vasculitis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Vasculitis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vasculitis Treatment Market Size (2019-2030)
9.2 Latin America Vasculitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Vasculitis Treatment Market Size by Country (2019-2024)
9.4 Latin America Vasculitis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vasculitis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Vasculitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Vasculitis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Vasculitis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Detail
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Vasculitis Treatment Introduction
11.1.4 Abbvie Revenue in Vasculitis Treatment Business (2019-2024)
11.1.5 Abbvie Recent Development
11.2 Ablynx
11.2.1 Ablynx Company Detail
11.2.2 Ablynx Business Overview
11.2.3 Ablynx Vasculitis Treatment Introduction
11.2.4 Ablynx Revenue in Vasculitis Treatment Business (2019-2024)
11.2.5 Ablynx Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Vasculitis Treatment Introduction
11.3.4 Amgen Revenue in Vasculitis Treatment Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 Anthera Pharmaceuticals
11.4.1 Anthera Pharmaceuticals Company Detail
11.4.2 Anthera Pharmaceuticals Business Overview
11.4.3 Anthera Pharmaceuticals Vasculitis Treatment Introduction
11.4.4 Anthera Pharmaceuticals Revenue in Vasculitis Treatment Business (2019-2024)
11.4.5 Anthera Pharmaceuticals Recent Development
11.5 Aspen Pharmacare Holdings
11.5.1 Aspen Pharmacare Holdings Company Detail
11.5.2 Aspen Pharmacare Holdings Business Overview
11.5.3 Aspen Pharmacare Holdings Vasculitis Treatment Introduction
11.5.4 Aspen Pharmacare Holdings Revenue in Vasculitis Treatment Business (2019-2024)
11.5.5 Aspen Pharmacare Holdings Recent Development
11.6 Astrazeneca
11.6.1 Astrazeneca Company Detail
11.6.2 Astrazeneca Business Overview
11.6.3 Astrazeneca Vasculitis Treatment Introduction
11.6.4 Astrazeneca Revenue in Vasculitis Treatment Business (2019-2024)
11.6.5 Astrazeneca Recent Development
11.7 Baxter
11.7.1 Baxter Company Detail
11.7.2 Baxter Business Overview
11.7.3 Baxter Vasculitis Treatment Introduction
11.7.4 Baxter Revenue in Vasculitis Treatment Business (2019-2024)
11.7.5 Baxter Recent Development
11.8 Biogen
11.8.1 Biogen Company Detail
11.8.2 Biogen Business Overview
11.8.3 Biogen Vasculitis Treatment Introduction
11.8.4 Biogen Revenue in Vasculitis Treatment Business (2019-2024)
11.8.5 Biogen Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Vasculitis Treatment Introduction
11.9.4 Bristol-Myers Squibb Revenue in Vasculitis Treatment Business (2019-2024)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Celgene
11.10.1 Celgene Company Detail
11.10.2 Celgene Business Overview
11.10.3 Celgene Vasculitis Treatment Introduction
11.10.4 Celgene Revenue in Vasculitis Treatment Business (2019-2024)
11.10.5 Celgene Recent Development
11.11 Celltrion
11.11.1 Celltrion Company Detail
11.11.2 Celltrion Business Overview
11.11.3 Celltrion Vasculitis Treatment Introduction
11.11.4 Celltrion Revenue in Vasculitis Treatment Business (2019-2024)
11.11.5 Celltrion Recent Development
11.12 Chemocentryx
11.12.1 Chemocentryx Company Detail
11.12.2 Chemocentryx Business Overview
11.12.3 Chemocentryx Vasculitis Treatment Introduction
11.12.4 Chemocentryx Revenue in Vasculitis Treatment Business (2019-2024)
11.12.5 Chemocentryx Recent Development
11.13 Chugai Pharma Usa
11.13.1 Chugai Pharma Usa Company Detail
11.13.2 Chugai Pharma Usa Business Overview
11.13.3 Chugai Pharma Usa Vasculitis Treatment Introduction
11.13.4 Chugai Pharma Usa Revenue in Vasculitis Treatment Business (2019-2024)
11.13.5 Chugai Pharma Usa Recent Development
11.14 Eisai
11.14.1 Eisai Company Detail
11.14.2 Eisai Business Overview
11.14.3 Eisai Vasculitis Treatment Introduction
11.14.4 Eisai Revenue in Vasculitis Treatment Business (2019-2024)
11.14.5 Eisai Recent Development
11.15 Eli Lilly
11.15.1 Eli Lilly Company Detail
11.15.2 Eli Lilly Business Overview
11.15.3 Eli Lilly Vasculitis Treatment Introduction
11.15.4 Eli Lilly Revenue in Vasculitis Treatment Business (2019-2024)
11.15.5 Eli Lilly Recent Development
11.16 F. Hoffmann-La Roche
11.16.1 F. Hoffmann-La Roche Company Detail
11.16.2 F. Hoffmann-La Roche Business Overview
11.16.3 F. Hoffmann-La Roche Vasculitis Treatment Introduction
11.16.4 F. Hoffmann-La Roche Revenue in Vasculitis Treatment Business (2019-2024)
11.16.5 F. Hoffmann-La Roche Recent Development
11.17 Genentech
11.17.1 Genentech Company Detail
11.17.2 Genentech Business Overview
11.17.3 Genentech Vasculitis Treatment Introduction
11.17.4 Genentech Revenue in Vasculitis Treatment Business (2019-2024)
11.17.5 Genentech Recent Development
11.18 Gilead
11.18.1 Gilead Company Detail
11.18.2 Gilead Business Overview
11.18.3 Gilead Vasculitis Treatment Introduction
11.18.4 Gilead Revenue in Vasculitis Treatment Business (2019-2024)
11.18.5 Gilead Recent Development
11.19 Glaxosmithkline
11.19.1 Glaxosmithkline Company Detail
11.19.2 Glaxosmithkline Business Overview
11.19.3 Glaxosmithkline Vasculitis Treatment Introduction
11.19.4 Glaxosmithkline Revenue in Vasculitis Treatment Business (2019-2024)
11.19.5 Glaxosmithkline Recent Development
11.20 Human Genome Sciences
11.20.1 Human Genome Sciences Company Detail
11.20.2 Human Genome Sciences Business Overview
11.20.3 Human Genome Sciences Vasculitis Treatment Introduction
11.20.4 Human Genome Sciences Revenue in Vasculitis Treatment Business (2019-2024)
11.20.5 Human Genome Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’